Cyclopharm Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was AUD 23.22 million compared to AUD 17.7 million a year ago. Revenue was AUD 24.96 million compared to AUD 20.14 million a year ago.

Net loss was AUD 6.61 million compared to AUD 5.04 million a year ago. Basic loss per share from continuing operations was AUD 0.0717 compared to AUD 0.0562 a year ago. Diluted loss per share from continuing operations was AUD 0.0717 compared to AUD 0.0562 a year ago.